home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

46.30 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Soleno Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗

April 29, 2024

Via Benzinga

SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q4 2023 ↗

March 06, 2024

SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/22

February 22, 2024

Via Investor Brand Network

Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/20

February 20, 2024

Via Investor Brand Network

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 29, 2024

Via Benzinga

Soleno Therapeutics Inc. (NASDAQ: SLNO) Climbs to New 52-Week High

January 09, 2024

Via Investor Brand Network

4 Analysts Have This to Say About Soleno Therapeutics ↗

November 21, 2023

Via Benzinga

Forget The Magnificent 7: Did Anyone Back These 1,000% Gainers In 2023? ↗

December 28, 2023

Baron Fifth Avenue Growth Fund gained nearly 60% over the year, while the Fidelity Blue Chip Growth ETF climbed 59%.

Via Benzinga

Topics ETFs

These Two Companies Surpass Nvidia, Apple And Microsoft with Astounding 1000% Returns In 2023 ↗

December 28, 2023

The two companies outperformed the 'Magnificent Seven' group of stocks, which includes tech giants such as Nvidia, Apple, and Microsoft.

Via Benzinga

Why Soleno Therapeutics Stock Ticked Higher on Thursday ↗

December 21, 2023

The latest pundit take on the stock provided a good reason for bulls to snap it up.

Via The Motley Fool

Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023 ↗

December 14, 2023

These three stocks to take profits on rallied more than 200% this year. Those gains are exceedingly unlikely to repeat in 2024.

Via InvestorPlace

3 Stock Winners That Are Up 500% or More in 2023 ↗

December 14, 2023

If you want to find 2023's top-performing stock, check out these companies that returned 500% or more since January

Via InvestorPlace

7 Stock Winners That Are Up 1,000% or More in 2023 ↗

December 12, 2023

Could any or all of these seven stocks up 1000% this year go on another hot run during 2024? Let's find out.

Via InvestorPlace

5 ‘Jackpot’ Stocks to Buy for 2024 for 10X Gains ↗

December 04, 2023

These stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent.

Via InvestorPlace

Feeling Lucky? 5 ‘Jackpot’ Stocks to Buy for 2024. ↗

November 27, 2023

When investors land on a "jackpot" stock, gains can offset even the steepest losses. Here are the top stocks to buy if you're feeling lucky.

Via InvestorPlace

3 Biotech Stocks With Big-Time Breakthrough Potential ↗

November 20, 2023

The biotech industry is filled with opportunity with these sure winners, pick up high-potential stocks like these and ride the wave.

Via InvestorPlace

The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA ↗

October 16, 2023

Some big 2023 winners are shorted heavily, including two AI plays.

Via Investor's Business Daily

Topics Artificial Intelligence

Top 5 Health Care Stocks That May Plunge In October ↗

October 04, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Meet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505% ↗

October 03, 2023

Soleno Therapeutics is working on a treatment for Prader Willi syndrome, a genetic disease that causes obesity.

Via Investor's Business Daily

Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review ↗

September 29, 2023

But it's not a confirmed uptrend yet. Nike, Amazon and Meta were in focus.

Via Investor's Business Daily

Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 28, 2023

Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...

Via Benzinga

Jabil, Chico's FAS And Other Big Stocks Moving Higher On Thursday ↗

September 28, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 28, 2023

Via Benzinga

Why Shares of Soleno Therapeutics Dropped on Wednesday ↗

September 27, 2023

Investors took profits a day after the clinical-stage biotech company's shares soared.

Via The Motley Fool

Don’t Miss the Boom: 3 ETFs Set to Explode Higher ↗

September 27, 2023

The market may be uncertain. But these three ETFs to buy are set to deliver fantastic returns regardless of the broader economic climate.

Via InvestorPlace

Topics ETFs

Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 27, 2023

Gainers

Via Benzinga

Shares of Soleno Therapeutics (NASDAQ: SLNO) Surge Over 500% After Its DCCR Candidate Shows Promise in PWS Clinical Trials

September 26, 2023

Breakthrough Results from Study C602 Soleno Therapeutics, Inc. (NASDAQ: SLNO), a trailblazer in the biopharmaceutical industry, recently unveiled its promising

Via Spotlight Growth

Soleno Therapeutics' Study Outcome Bolsters Confidence In PWS Treatment ↗

September 26, 2023

Earlier on Tuesday, Soleno Therapeutics Inc (NASDAQ: SLNO) released top-line results from the randomized withdrawal period of Study C602, a long-term treatment study of DCCR (Diazoxide Choline)...

Via Benzinga

Nasdaq Down 1.5%; Immunovant Shares Spike Higher ↗

September 26, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 400 points on Tuesday. The Dow traded down 1.19% to 33,601.60 while the NASDAQ fell 1.48% to 13,074.97. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 26, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com